Shareholders Equity ratio Analysis of GlaxoSmithKline PLC ADR - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointShareholders Equity of GSK
Dec-2322.62Not Good Shareholders Equity | Dec-2217.62Poor Shareholders Equity | Growth28.37% |
Shareholders Equity Analysis of GlaxoSmithKline PLC ADR
| Shareholders Equity Ratio of GSK rose handsomely by 28.37 % this year. |
| Shareholders Equity Ratio with value of 22.62 was highest in Year Dec-23 in last Five Years. |
| Shareholders Equity Ratio with value of 14.31 was lowest in Year Dec-19 in last Five Years. |
| Latest Shareholders Equity Ratio with value of 22.62 is Greater than Average Shareholders Equity of 18.34 in last five years. |
Other Shareholders Equity Related Info of GSK that may interest you.
GlaxoSmithKline PLC ADR Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| GSK | 44.77 | 44.02 | 1.70 % | Drug Manufacturers-General |
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation. more ..
Shareholders Equity Related Ratios
| DebtToEquityRatio | ReturnOnEquity |
Tsr Stability Index
| Low Stability Stock | |
FY - Historical Shareholders Equity of GlaxoSmithKline PLC ADR
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| Shareholders Equity | 22.62 | 17.62 | 19.03 | 18.14 | 14.31 | 7.51 | -0.121 |
| Change | 28.37 % | -7.42 % | 4.94 % | 26.72 % | 90.60 % | 6325.70 % | -106.34 % |
FY Chart of Shareholders Equity of GlaxoSmithKline PLC ADR
Note : All Data Generated at the End of Trading Hours (EOD Data)